Systimmune
SystImmune, a clinical-stage biopharmaceutical company focusing on cancer treatments, is expanding its AI and computational discovery team. The company develops biologics like bispecific antibodies and ADCs, and seeks a Machine Learning Scientist to advance drug discovery and therapeutic design through AI applications, collaborating across scientific disciplines.
Headquarters
Redmond, Washington, United States
Company Size
11-50 employees
Founded
2014
SystImmune is a Redmond, WA–based biopharmaceutical company developing bi‑specific and multi‑specific antibodies and antibody‑drug conjugates (ADCs) to treat cancer. Its mission is to create biologics that both directly attack tumors and activate the immune system to enhance anti‑tumor responses, using proprietary protein‑engineering and antibody‑discovery platforms. A multidisciplinary team across the U.S. and China focuses on rapid, cost‑efficient clinical development. SystImmune is a member of the Biokin Pharmaceutical group and partners with Bristol Myers Squibb and OrbiMed, and it is seeking additional collaborators to develop and commercialize its therapies worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Systimmune.
19% below the average for this role
Senior Scientist/Associate Principal Scientist, AI
AstraZeneca
Senior/Staff Machine Learning Bioinformatics Scientist
Protillion Biosciences
Senior/Principal AI Scientist for Large Molecule - AIDD
Roche
Senior Scientist – Biologics AI Innovation
AstraZeneca
Principal Scientist, Machine Learning - Biomolecules
Flagship Pioneering, Inc.
Research Scientist: Machine Learning for Drug Discovery and Genomic Data
Accenture